
Vaccine Boost Fading For Big Pharma, Leading To Cost Cuts In Biotech
The global emergency effort to devise and deliver coronavirus vaccines was a shot in the arm for many large pharmaceutical companies, leading to rising profits, extensive reinvestment in research and vast expansions of biomanufacturing capacity. […]